Therion Biologics Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Therion Biologics Corporation - overview
Established
1991
Location
Cambridge, MA, US
Primary Industry
Pharmaceuticals
About
Therion Biologics Corporation is a pharmaceuticals company that develops therapeutic vaccines for cancer and preventive vaccines for AIDS.
Current Investors
SR One, Hambrecht & Quist, Cheng Xin Venture Capital Group
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.